Live Database

Opportunities
Search

Search the internal Cuberfy opportunities database for grants, startup programs, tenders, cloud credits and funding calls.

Searching the internal opportunities database and preparing the best matching records.
All Tenders Grants Funding Projects
48578 opportunities · Page 1732 of 1944
Save after changing Favorites. Use Share Link when you want the same list on another device.
Your link (Favorites):
TEN
Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130a Abs. 8 SGB V (Open-House-Modell)
ted.europa.eu
Buyer: AOK - Die Gesundheitskasse in Hessen Postanschrift: Kölner Str. 8, 65760 Eschborn Land: Deutschland Kontaktstelle(n): z. Hd. Frau Corinna Varel...
Tender Procurement Contract Germany Open
AmountNot provided on the source page. Please check the official source.
DeadlineOct 1, 2027
Buyer: AOK - Die Gesundheitskasse in Hessen Postanschrift: Kölner Str. 8, 65760 Eschborn Land: Deutschland Kontaktstelle(n): z. Hd. Frau Corinna Varelmann E-Mail: am-vertragsteam@he.aok.de Telefon: +49 69 6681 6259 711 Internet-Adresse(n):Hauptadresse: http://www.aok.de/hessen/ | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-01
TEN
Germany – Pharmaceutical products – Arzneimittel-Rabattverträge ab 01.12.2025 zu diversen Wirkstoffen im Rahmen eines Open-House-Verfahrens
ted.europa.eu
Buyer: AOK NordWest | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-01
Tender Procurement Contract Germany Open
AmountNot provided on the source page. Please check the official source.
DeadlineOct 1, 2027
Buyer: AOK NordWest | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-01
TEN
Germany – Pharmaceutical products – Abschluss von Vereinbarungen zur wirtschaftlichen Versorgung von Kontrastmitteln im Rahmen eines Open House Modells
ted.europa.eu
Buyer: AOK - Die Gesundheitskasse in Hessen Postanschrift: Kölner Str. 8, 65760 Eschborn Land: Deutschland Kontaktstelle(n): z. Hd. Frau Camelia Weikl...
Tender Procurement Contract Germany Open
AmountNot provided on the source page. Please check the official source.
DeadlineOct 1, 2027
Buyer: AOK - Die Gesundheitskasse in Hessen Postanschrift: Kölner Str. 8, 65760 Eschborn Land: Deutschland Kontaktstelle(n): z. Hd. Frau Camelia Weikl E-Mail: SSB_Ausschreibung@he.aok.de Telefon: +496966816251323 Internet-Adresse(n):Hauptadresse: http://www.aok.de/hessen/ | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-01
TEN
Poland – Portable computers – Dostawa laptopów na rzecz sądów powszechnych
ted.europa.eu
Buyer: Centrum Zakupów dla Sądownictwa Instytucja Gospodarki Budżetowej reprezentująca Sąd Apelacyjny w Krakowie | Notice type: cn-standard | Procedur...
Tender Procurement Contract Poland Open
AmountNot provided on the source page. Please check the official source.
DeadlineOct 2, 2027
Buyer: Centrum Zakupów dla Sądownictwa Instytucja Gospodarki Budżetowej reprezentująca Sąd Apelacyjny w Krakowie | Notice type: cn-standard | Procedure: restricted | Contract: supplies | Deadline: 2027-10-02
TEN
France – Repair and maintenance services of medical equipment – GCS UniHA - Maintenance en Imagerie Médicale (MAINTIM 2020) SAD
ted.europa.eu
Buyer: GCS UniHA | Notice type: cn-standard | Procedure: restricted | Contract: services | Deadline: 2027-10-03
Tender Procurement Contract France Open
AmountNot provided on the source page. Please check the official source.
DeadlineOct 3, 2027
Buyer: GCS UniHA | Notice type: cn-standard | Procedure: restricted | Contract: services | Deadline: 2027-10-03
TEN
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Risankizumab, ATC L04AC18
ted.europa.eu
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-03
Tender Procurement Contract Germany Open
AmountNot provided on the source page. Please check the official source.
DeadlineOct 3, 2027
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-03
TEN
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Allergenextrakte aus Gräserpollen zur sublingualen Anwendung, Handelsbezeichnung Oralair(R), ATC V01AA02
ted.europa.eu
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-03
Tender Procurement Contract Germany Open
AmountNot provided on the source page. Please check the official source.
DeadlineOct 3, 2027
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-03
TEN
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Natalizumab in der Darreichungsform Konz.z.Herst.e.Inf.-Lsg. , ATC L04AG03
ted.europa.eu
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-03
Tender Procurement Contract Germany Open
AmountNot provided on the source page. Please check the official source.
DeadlineOct 3, 2027
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-03
TEN
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Pegfilgrastim, ATC L03AA13
ted.europa.eu
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-03
Tender Procurement Contract Germany Open
AmountNot provided on the source page. Please check the official source.
DeadlineOct 3, 2027
Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-03
GRA
BRAIN Initiative Connectivity across Scales (BRAIN CONNECTS): Specialized Projects for Scalable Technologies (U01 Clinical Trial Not Allowed)
grants.gov
This funding announcement, issued by the Brain Research through Advancing Innovative Neurotechnologies® (BRAIN) Initiative, seeks transformative, cutt...
Grant Mixed United States Open
AmountNot provided on the source page. Please check the official source.
DeadlineOct 4, 2027
This funding announcement, issued by the Brain Research through Advancing Innovative Neurotechnologies® (BRAIN) Initiative, seeks transformative, cutting-edge, and innovative research that embraces new technologies, ideas, and approaches to understand brain circuit function and contributions to behavior. It is a component of the BRAIN Initiative Connectivity Across Scales (BRAIN CONNECTS) Program, which aims to lay the scientific foundation for the next generation of neural circuit-based approaches for preventing and treating devastating brain disorders.This Notice of Funding Opportunity (NOFO) supports Specialized Projects to develop current or emerging technologies to generate comprehensive atlases of brain connectivity, with an emphasis on human, non-human primate (NHP), and mouse. Projects using other species are also permitted, if their use is well justified and the goal is to test and validate approaches that can be generalized across species. Applications may address any aspect(...
TEN
Germany – Pharmaceutical products – Offene Rahmenvereinbarung über Arzneimittelrabatte gemäß § 130a Abs.8 SGB V mit jederzeitiger Beitrittsmöglichkeit, sog. Zulassungsmodell 2025-10
ted.europa.eu
Buyer: Deutsche Rentenversicherung Knappschaft-Bahn-See | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-05
Tender Procurement Contract Germany Open
AmountNot provided on the source page. Please check the official source.
DeadlineOct 5, 2027
Buyer: Deutsche Rentenversicherung Knappschaft-Bahn-See | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-05
TEN
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Abirateron (ausschließlich 500 mg 90 Stück), ATC L02BX03 für die Zeit 01.12.2025 - 30.11.2027
ted.europa.eu
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-05
Tender Procurement Contract Germany Open
AmountNot provided on the source page. Please check the official source.
DeadlineOct 5, 2027
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-05
TEN
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Leuprorelin, ATC L02AE02 für die Zeit 01.12.2025 - 30.11.2027
ted.europa.eu
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-05
Tender Procurement Contract Germany Open
AmountNot provided on the source page. Please check the official source.
DeadlineOct 5, 2027
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-05
TEN
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Natalizumab (ausschl. in der Dafo. IFK), f. d. Zeit 01.12.25 - 30.11.26 (zzgl. Verlängerungsoption 1x12 Mon)
ted.europa.eu
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-05
Tender Procurement Contract Germany Open
AmountNot provided on the source page. Please check the official source.
DeadlineOct 5, 2027
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-05
TEN
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Doravirin + Lamivudin + Tenofovirdisoproxilfumarat, ATC J05AR24 für die Zeit 01.12.2025 - 30.11.2027
ted.europa.eu
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-05
Tender Procurement Contract Germany Open
AmountNot provided on the source page. Please check the official source.
DeadlineOct 5, 2027
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-05
TEN
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Aflibercept (ausgenommen 114,3 mg/ml), ATC S01LA05 für die Zeit 01.12.2025 - 30.11.2027
ted.europa.eu
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-05
Tender Procurement Contract Germany Open
AmountNot provided on the source page. Please check the official source.
DeadlineOct 5, 2027
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-05
TEN
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Doravirin, ATC J05AG06 für die Zeit 01.12.2025 - 30.11.2027
ted.europa.eu
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-05
Tender Procurement Contract Germany Open
AmountNot provided on the source page. Please check the official source.
DeadlineOct 5, 2027
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-05
TEN
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Tocilizumab (ausschließlich Fertigspritze und Fertigpen), ATC L04AC07 für die Zeit 01.12.2025 - 30.11.2027
ted.europa.eu
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-05
Tender Procurement Contract Germany Open
AmountNot provided on the source page. Please check the official source.
DeadlineOct 5, 2027
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-05
TEN
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Haloperidol (ausschließlich Injektionslösung), ATC N05AD01 für die Zeit 01.12.2025 - 30.11.2027
ted.europa.eu
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-05
Tender Procurement Contract Germany Open
AmountNot provided on the source page. Please check the official source.
DeadlineOct 5, 2027
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-05
TEN
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Tocilizumab (ausschließlich Infusionslösungskonzentrat), ATC L04AC07 für die Zeit 01.12.2025 - 30.11.2027
ted.europa.eu
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-05
Tender Procurement Contract Germany Open
AmountNot provided on the source page. Please check the official source.
DeadlineOct 5, 2027
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-05
TEN
Germany – Pharmaceutical products – Offene Rahmenvereinbarung über Arzneimittelrabatte gemäß § 130a Abs.8 SGB V mit jederzeitiger Beitrittsmöglichkeit, sog. Zulassungsmodell 2025-10
ted.europa.eu
Buyer: Deutsche Rentenversicherung Knappschaft-Bahn-See | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-05
Tender Procurement Contract Germany Open
AmountNot provided on the source page. Please check the official source.
DeadlineOct 5, 2027
Buyer: Deutsche Rentenversicherung Knappschaft-Bahn-See | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-05
TEN
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Sumatriptan (ausgenommen Filmtabletten und Tabletten), ATC N02CC01 für die Zeit 01.12.2025 - 30.11.2027
ted.europa.eu
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-05
Tender Procurement Contract Germany Open
AmountNot provided on the source page. Please check the official source.
DeadlineOct 5, 2027
Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-05
RES
Hydrogen cities
ec.europa.eu
Expected Outcome:A growing number of cities across Europe is developing hydrogen strategies, either for mobility applications or for decarbonising the...
Research Funding Cash Grant Europe Open
AmountExpected EU contribution: 5,000,000 EUR - 5,000,000 EUR
DeadlineOct 7, 2027
Expected Outcome:A growing number of cities across Europe is developing hydrogen strategies, either for mobility applications or for decarbonising their local and peri-urban industries and hard-to-abate sectors. By acting as experimentation and innovation hubs, these cities can be testbeds for the energy transition, balancing decarbonisation with competitiveness and social cohesion.Project results are expected to contribute to the following expected outcomes:Investments in - and deployment of - hydrogen applications and infrastructure for hard-to-abate sectors in and around cities to mitigate local air pollution and lead to economic growth and jobs, bringing urban environments at the forefront of sustainability and innovation.Communities of practice to foster the interaction between stakeholders from cities, ports, industry, local and regional government, as well as researchers and citiz...
RES
Inclusive and climate resilient multimodal passenger hubs enhancing modal shift towards sustainable transport and shared mobility
ec.europa.eu
Expected Outcome:Project results are expected to contribute to all the following outcomes:Contribute to the objectives of the Climate-Neutral and Smar...
Research Funding Cash Grant Europe Open
AmountExpected EU contribution: 9,000,000 EUR - 9,000,000 EUR
DeadlineOct 7, 2027
Expected Outcome:Project results are expected to contribute to all the following outcomes:Contribute to the objectives of the Climate-Neutral and Smart Cities Mission by accelerating the transition towards climate neutrality targets in cities and reducing greenhouse gas and air pollutants emissions from transport due to the improved operation of the multimodal hubs.Reduce road congestion and improve air quality to protect health of citizens and urban biodiversity, by increasing shift towards sustainable and active modes of transport for city and intercity trips.Contribute to the objectives of the TEN-T Regulation by enhancing the climate resilience of multimodal passenger hub infrastructures and services in response to both the long-term effects of climate change and extreme weather eventsIncrease inclusivity, accessibility and improved experience for all passengers at multimodal hubs, b...
RES
Innovative microgrids for improved energy system integration and efficiency in urban contexts
ec.europa.eu
Expected Outcome:Projects are expected to contribute to all the following outcomes:Improved awareness of the potential of Low Voltage Direct Current (...
Research Funding Cash Grant Europe Open
AmountExpected EU contribution: 7,000,000 EUR - 7,000,000 EUR
DeadlineOct 7, 2027
Expected Outcome:Projects are expected to contribute to all the following outcomes:Improved awareness of the potential of Low Voltage Direct Current (LVDC) microgrids to support the goals of the European Green Deal and the Clean Industrial Deal, including as defined under the SET Plan[1] and the Solar Strategy[2].Increased acceptance of LVDC microgrids in Europe, with significant and measurable contributions to human and building safety (notably with respect to DC faults), energy and resource efficiency, integration of renewables & storage and demand response, peak power shaving, resilience, and (where applicable) established proof of concept on how LVDC microgrids can enable energy communities[3] to share energy assets and increase self-consumption of local renewables sources.Increased uptake in European cities, facilitated by technical guidelines for installation of LVDC microgrids and...
📅 Best viewed on desktop - or rotate your phone to landscape mode.
# Opportunity Type Region / Country Amount Deadline Source
43276 Germany – Pharmaceutical products – Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130a Abs. 8 SGB V (Open-House-Modell) Buyer: AOK - Die Gesundheitskasse in Hessen Postanschrift: Kölner Str. 8, 65760 Eschborn Land: Deutschland Kontaktstelle(n): z. Hd... Tender Procurement Contract Germany Not provided on the source page. Please check the official source. Open Oct 1, 2027 Open TED / Tenders Electronic Daily
Source description

Buyer: AOK - Die Gesundheitskasse in Hessen Postanschrift: Kölner Str. 8, 65760 Eschborn Land: Deutschland Kontaktstelle(n): z. Hd. Frau Corinna Varelmann E-Mail: am-vertragsteam@he.aok.de Telefon: +49 69 6681 6259 711 Internet-Adresse(n):Hauptadresse: http://www.aok.de/hessen/ | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-01

43277 Germany – Pharmaceutical products – Arzneimittel-Rabattverträge ab 01.12.2025 zu diversen Wirkstoffen im Rahmen eines Open-House-Verfahrens Buyer: AOK NordWest | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-01 Tender Procurement Contract Germany Not provided on the source page. Please check the official source. Open Oct 1, 2027 Open TED / Tenders Electronic Daily
Source description

Buyer: AOK NordWest | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-01

43278 Germany – Pharmaceutical products – Abschluss von Vereinbarungen zur wirtschaftlichen Versorgung von Kontrastmitteln im Rahmen eines Open House Modells Buyer: AOK - Die Gesundheitskasse in Hessen Postanschrift: Kölner Str. 8, 65760 Eschborn Land: Deutschland Kontaktstelle(n): z. Hd... Tender Procurement Contract Germany Not provided on the source page. Please check the official source. Open Oct 1, 2027 Open TED / Tenders Electronic Daily
Source description

Buyer: AOK - Die Gesundheitskasse in Hessen Postanschrift: Kölner Str. 8, 65760 Eschborn Land: Deutschland Kontaktstelle(n): z. Hd. Frau Camelia Weikl E-Mail: SSB_Ausschreibung@he.aok.de Telefon: +496966816251323 Internet-Adresse(n):Hauptadresse: http://www.aok.de/hessen/ | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-01

43279 Poland – Portable computers – Dostawa laptopów na rzecz sądów powszechnych Buyer: Centrum Zakupów dla Sądownictwa Instytucja Gospodarki Budżetowej reprezentująca Sąd Apelacyjny w Krakowie | Notice type: cn... Tender Procurement Contract Poland Not provided on the source page. Please check the official source. Open Oct 2, 2027 Open TED / Tenders Electronic Daily
Source description

Buyer: Centrum Zakupów dla Sądownictwa Instytucja Gospodarki Budżetowej reprezentująca Sąd Apelacyjny w Krakowie | Notice type: cn-standard | Procedure: restricted | Contract: supplies | Deadline: 2027-10-02

43280 France – Repair and maintenance services of medical equipment – GCS UniHA - Maintenance en Imagerie Médicale (MAINTIM 2020) SAD Buyer: GCS UniHA | Notice type: cn-standard | Procedure: restricted | Contract: services | Deadline: 2027-10-03 Tender Procurement Contract France Not provided on the source page. Please check the official source. Open Oct 3, 2027 Open TED / Tenders Electronic Daily
Source description

Buyer: GCS UniHA | Notice type: cn-standard | Procedure: restricted | Contract: services | Deadline: 2027-10-03

43281 Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Risankizumab, ATC L04AC18 Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-03 Tender Procurement Contract Germany Not provided on the source page. Please check the official source. Open Oct 3, 2027 Open TED / Tenders Electronic Daily
Source description

Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-03

43282 Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Allergenextrakte aus Gräserpollen zur sublingualen Anwendung, Handelsbezeichnung Oralair(R), ATC V01AA02 Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-03 Tender Procurement Contract Germany Not provided on the source page. Please check the official source. Open Oct 3, 2027 Open TED / Tenders Electronic Daily
Source description

Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-03

43283 Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Natalizumab in der Darreichungsform Konz.z.Herst.e.Inf.-Lsg. , ATC L04AG03 Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-03 Tender Procurement Contract Germany Not provided on the source page. Please check the official source. Open Oct 3, 2027 Open TED / Tenders Electronic Daily
Source description

Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-03

43284 Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Pegfilgrastim, ATC L03AA13 Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-03 Tender Procurement Contract Germany Not provided on the source page. Please check the official source. Open Oct 3, 2027 Open TED / Tenders Electronic Daily
Source description

Buyer: AOK Bayern - Die Gesundheitskasse | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-03

43285 BRAIN Initiative Connectivity across Scales (BRAIN CONNECTS): Specialized Projects for Scalable Technologies (U01 Clinical Trial Not Allowed) This funding announcement, issued by the Brain Research through Advancing Innovative Neurotechnologies® (BRAIN) Initiative, seeks... Grant Mixed United States Not provided on the source page. Please check the official source. Open Oct 4, 2027 Open Grants.gov
Source description

This funding announcement, issued by the Brain Research through Advancing Innovative Neurotechnologies® (BRAIN) Initiative, seeks transformative, cutting-edge, and innovative research that embraces new technologies, ideas, and approaches to understand brain circuit function and contributions to behavior. It is a component of the BRAIN Initiative Connectivity Across Scales (BRAIN CONNECTS) Program, which aims to lay the scientific foundation for the next generation of neural circuit-based approaches for preventing and treating devastating brain disorders.This Notice of Funding Opportunity (NOFO) supports Specialized Projects to develop current or emerging technologies to generate comprehensive atlases of brain connectivity, with an emphasis on human, non-human primate (NHP), and mouse. Projects using other species are also permitted, if their use is well justified and the goal is to test and validate approaches that can be generalized across species. Applications may address any aspect(s) of brain connectivity and associated data pipelines, including data collection, reconstruction, analysis, integration, dissemination, and interpretation, to enable faster, more precise, and more cost-effective generation and interpretation of brain-wide wiring diagrams. Funded projects will be integrated into the BRAIN CONNECTS Network consisting of projects funded under this and preceding BRAIN CONNECTS NOFOs, as a coordinated effort aimed at developing the capabilities to generate wiring diagrams that can span entire brains across multiple scales.

43286 Germany – Pharmaceutical products – Offene Rahmenvereinbarung über Arzneimittelrabatte gemäß § 130a Abs.8 SGB V mit jederzeitiger Beitrittsmöglichkeit, sog. Zulassungsmodell 2025-10 Buyer: Deutsche Rentenversicherung Knappschaft-Bahn-See | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadli... Tender Procurement Contract Germany Not provided on the source page. Please check the official source. Open Oct 5, 2027 Open TED / Tenders Electronic Daily
Source description

Buyer: Deutsche Rentenversicherung Knappschaft-Bahn-See | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-05

43287 Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Abirateron (ausschließlich 500 mg 90 Stück), ATC L02BX03 für die Zeit 01.12.2025 - 30.11.2027 Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-05 Tender Procurement Contract Germany Not provided on the source page. Please check the official source. Open Oct 5, 2027 Open TED / Tenders Electronic Daily
Source description

Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-05

43288 Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Leuprorelin, ATC L02AE02 für die Zeit 01.12.2025 - 30.11.2027 Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-05 Tender Procurement Contract Germany Not provided on the source page. Please check the official source. Open Oct 5, 2027 Open TED / Tenders Electronic Daily
Source description

Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-05

43289 Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Natalizumab (ausschl. in der Dafo. IFK), f. d. Zeit 01.12.25 - 30.11.26 (zzgl. Verlängerungsoption 1x12 Mon) Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-05 Tender Procurement Contract Germany Not provided on the source page. Please check the official source. Open Oct 5, 2027 Open TED / Tenders Electronic Daily
Source description

Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-05

43290 Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Doravirin + Lamivudin + Tenofovirdisoproxilfumarat, ATC J05AR24 für die Zeit 01.12.2025 - 30.11.2027 Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-05 Tender Procurement Contract Germany Not provided on the source page. Please check the official source. Open Oct 5, 2027 Open TED / Tenders Electronic Daily
Source description

Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-05

43291 Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Aflibercept (ausgenommen 114,3 mg/ml), ATC S01LA05 für die Zeit 01.12.2025 - 30.11.2027 Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-05 Tender Procurement Contract Germany Not provided on the source page. Please check the official source. Open Oct 5, 2027 Open TED / Tenders Electronic Daily
Source description

Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-05

43292 Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Doravirin, ATC J05AG06 für die Zeit 01.12.2025 - 30.11.2027 Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-05 Tender Procurement Contract Germany Not provided on the source page. Please check the official source. Open Oct 5, 2027 Open TED / Tenders Electronic Daily
Source description

Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-05

43293 Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Tocilizumab (ausschließlich Fertigspritze und Fertigpen), ATC L04AC07 für die Zeit 01.12.2025 - 30.11.2027 Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-05 Tender Procurement Contract Germany Not provided on the source page. Please check the official source. Open Oct 5, 2027 Open TED / Tenders Electronic Daily
Source description

Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-05

43294 Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Haloperidol (ausschließlich Injektionslösung), ATC N05AD01 für die Zeit 01.12.2025 - 30.11.2027 Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-05 Tender Procurement Contract Germany Not provided on the source page. Please check the official source. Open Oct 5, 2027 Open TED / Tenders Electronic Daily
Source description

Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-05

43295 Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Tocilizumab (ausschließlich Infusionslösungskonzentrat), ATC L04AC07 für die Zeit 01.12.2025 - 30.11.2027 Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-05 Tender Procurement Contract Germany Not provided on the source page. Please check the official source. Open Oct 5, 2027 Open TED / Tenders Electronic Daily
Source description

Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-05

43296 Germany – Pharmaceutical products – Offene Rahmenvereinbarung über Arzneimittelrabatte gemäß § 130a Abs.8 SGB V mit jederzeitiger Beitrittsmöglichkeit, sog. Zulassungsmodell 2025-10 Buyer: Deutsche Rentenversicherung Knappschaft-Bahn-See | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadli... Tender Procurement Contract Germany Not provided on the source page. Please check the official source. Open Oct 5, 2027 Open TED / Tenders Electronic Daily
Source description

Buyer: Deutsche Rentenversicherung Knappschaft-Bahn-See | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-05

43297 Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Sumatriptan (ausgenommen Filmtabletten und Tabletten), ATC N02CC01 für die Zeit 01.12.2025 - 30.11.2027 Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-05 Tender Procurement Contract Germany Not provided on the source page. Please check the official source. Open Oct 5, 2027 Open TED / Tenders Electronic Daily
Source description

Buyer: DAK-Gesundheit | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-10-05

43298 Hydrogen cities Expected Outcome:A growing number of cities across Europe is developing hydrogen strategies, either for mobility applications or f... Research Funding Cash Grant Europe Expected EU contribution: 5,000,000 EUR - 5,000,000 EUR Open Oct 7, 2027 Open EU Funding & Tenders Portal
Source description

Expected Outcome:A growing number of cities across Europe is developing hydrogen strategies, either for mobility applications or for decarbonising their local and peri-urban industries and hard-to-abate sectors. By acting as experimentation and innovation hubs, these cities can be testbeds for the energy transition, balancing decarbonisation with competitiveness and social cohesion.Project results are expected to contribute to the following expected outcomes:Investments in - and deployment of - hydrogen applications and infrastructure for hard-to-abate sectors in and around cities to mitigate local air pollution and lead to economic growth and jobs, bringing urban environments at the forefront of sustainability and innovation.Communities of practice to foster the interaction between stakeholders from cities, ports, industry, local and regional government, as well as researchers and citiz...

43299 Inclusive and climate resilient multimodal passenger hubs enhancing modal shift towards sustainable transport and shared mobility Expected Outcome:Project results are expected to contribute to all the following outcomes:Contribute to the objectives of the Clim... Research Funding Cash Grant Europe Expected EU contribution: 9,000,000 EUR - 9,000,000 EUR Open Oct 7, 2027 Open EU Funding & Tenders Portal
Source description

Expected Outcome:Project results are expected to contribute to all the following outcomes:Contribute to the objectives of the Climate-Neutral and Smart Cities Mission by accelerating the transition towards climate neutrality targets in cities and reducing greenhouse gas and air pollutants emissions from transport due to the improved operation of the multimodal hubs.Reduce road congestion and improve air quality to protect health of citizens and urban biodiversity, by increasing shift towards sustainable and active modes of transport for city and intercity trips.Contribute to the objectives of the TEN-T Regulation by enhancing the climate resilience of multimodal passenger hub infrastructures and services in response to both the long-term effects of climate change and extreme weather eventsIncrease inclusivity, accessibility and improved experience for all passengers at multimodal hubs, b...

43300 Innovative microgrids for improved energy system integration and efficiency in urban contexts Expected Outcome:Projects are expected to contribute to all the following outcomes:Improved awareness of the potential of Low Volt... Research Funding Cash Grant Europe Expected EU contribution: 7,000,000 EUR - 7,000,000 EUR Open Oct 7, 2027 Open EU Funding & Tenders Portal
Source description

Expected Outcome:Projects are expected to contribute to all the following outcomes:Improved awareness of the potential of Low Voltage Direct Current (LVDC) microgrids to support the goals of the European Green Deal and the Clean Industrial Deal, including as defined under the SET Plan[1] and the Solar Strategy[2].Increased acceptance of LVDC microgrids in Europe, with significant and measurable contributions to human and building safety (notably with respect to DC faults), energy and resource efficiency, integration of renewables & storage and demand response, peak power shaving, resilience, and (where applicable) established proof of concept on how LVDC microgrids can enable energy communities[3] to share energy assets and increase self-consumption of local renewables sources.Increased uptake in European cities, facilitated by technical guidelines for installation of LVDC microgrids and...